LH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 21:58):

Stats
Šios dienos apimtis	300 440
Vidutinė apimtis	799 177
Rinkos kapitalizacija	16.85B
EPS	$0 ( 2024-04-25 )
Kita pelno data	( $3.80 ) 2024-07-25
Last Dividend	$0.720 ( 2023-11-07 )
Next Dividend	$0 ( N/A )
P/E	42.90
ATR14	$0.0670 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Eisenberg Glenn A	Buy	10 229	Common Stock
2024-04-30	Eisenberg Glenn A	Sell	4 496	Common Stock
2024-04-30	Eisenberg Glenn A	Sell	10 229	Performance Share Unit
2024-04-29	Wilkinson Peter J	Sell	2 439	Common Stock
2024-04-15	Eisenberg Glenn A	Buy	10 229	Common Stock

INSIDER POWER
-10.89
Last 100 transactions
Buy: 259 814 \| Sell: 318 541

Tūris Koreliacija

Ilgas: 0.22 (neutral)

Trumpas: -0.98 (very strong negative)

Signal:(51.899) Neutral

Laboratory Corporation of Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Laboratory Corporation of Koreliacija - Valiuta/Žaliavos

-0.30
( neutral )

-0.59
( weak negative )

-0.69
( moderate negative )

-0.18
( neutral )

0.74
( moderate )

0.68
( moderate )

Laboratory Corporation of Finansinės ataskaitos

Annual	2023
Pajamos:	$12.16B
Bruto pelnas:	$3.15B (25.86 %)
EPS:	$4.80

FY	2023
Pajamos:	$12.16B
Bruto pelnas:	$3.15B (25.86 %)
EPS:	$4.80

FY	2022
Pajamos:	$14.88B
Bruto pelnas:	$4.39B (29.48 %)
EPS:	$14.04

FY	2021
Pajamos:	$16.12B
Bruto pelnas:	$5.62B (34.89 %)
EPS:	$24.60

Financial Reports:

No articles found.

Laboratory Corporation of Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.720 (N/A)	$0.720 (N/A)	$0.720 (N/A)	$0.720 (N/A)	$0.720 (N/A)	$0.720 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Laboratory Corporation of Dividend Information - Dividend Junior

Dividend Sustainability Score: 8.88 - good (88.78%) | Divividend Growth Potential Score: 3.15 - Decrease likely (37.01%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	1990-12-31
Last Dividend	$0.720	2023-11-07
Next Dividend	$0	N/A
Payout Date	2023-12-12
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	$7.64	--
Avg. Dividend % Per Year	0.54%	--
Score	2.43	--
Div. Sustainability Score	8.88
Div.Growth Potential Score	3.15
Div. Directional Score	6.01	--

Next Divdend (Est)
(2025-06-04)

$0.751 Estimate 31.20 %

Dividend Stability

0.62 Above Average

Dividend Score

2.43

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
1990	$0.150	0.61%
1991	$0.500	2.19%
1992	$0.950	1.59%
1993	$0.800	2.11%
1994	$0.200	0.65%
1995	$0	0.00%
1996	$0	0.00%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$2.16	0.84%
2023	$2.88	1.41%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0352	1.500	9.30	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0262	1.200	9.13	10.00	[0 - 0.3]
returnOnEquityTTM	0.0533	1.500	-0.518	-0.778	[0.1 - 1]
payoutRatioTTM	0.581	-1.000	4.19	-4.19	[0 - 1]
currentRatioTTM	0.877	0.800	-0.615	-0.492	[1 - 3]
quickRatioTTM	0.584	0.800	-1.268	-1.015	[0.8 - 2.5]
cashRatioTTM	0.0252	1.500	-0.971	-1.457	[0.2 - 2]
debtRatioTTM	0.319	-1.500	4.69	-7.03	[0 - 0.6]
interestCoverageTTM	5.50	1.000	9.07	9.07	[3 - 30]
operatingCashFlowPerShareTTM	13.99	2.00	5.34	10.00	[0 - 30]
freeCashFlowPerShareTTM	7.95	2.00	6.03	10.00	[0 - 20]
debtEquityRatioTTM	0.662	-1.500	7.35	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.268	1.000	8.87	8.87	[0.2 - 0.8]
operatingProfitMarginTTM	0.0875	1.000	-0.249	-0.249	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.223	1.000	9.87	9.87	[0.2 - 2]
assetTurnoverTTM	0.744	0.800	8.37	6.70	[0.5 - 2]
Total Score				8.88

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	39.09	1.000	6.15	0	[1 - 100]
returnOnEquityTTM	0.0533	2.50	-0.333	-0.778	[0.1 - 1.5]
freeCashFlowPerShareTTM	7.95	2.00	7.35	10.00	[0 - 30]
dividendYielPercentageTTM	1.431	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	13.99	2.00	5.34	10.00	[0 - 30]
payoutRatioTTM	0.581	1.500	4.19	-4.19	[0 - 1]
pegRatioTTM	-1.464	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0957	1.000	-0.108	0	[0.1 - 0.5]
Total Score				3.15

Laboratory Corporation of

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.